Imperial Ginseng Products Ltd.
IGP.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 32.86% | -94.28% | -99.19% | -99.33% | -99.57% |
| Gross Profit | -32.86% | 94.28% | 95.55% | -104.23% | 27.08% |
| SG&A Expenses | -76.51% | -89.21% | -89.47% | -84.97% | -72.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -73.65% | -90.34% | -95.47% | -92.59% | -89.47% |
| Operating Income | 73.65% | 90.34% | 90.86% | 80.74% | 71.62% |
| Income Before Tax | -165.33% | -96.10% | -95.60% | -94.91% | -93.01% |
| Income Tax Expenses | -120.70% | -101.49% | -101.50% | -101.21% | -93.44% |
| Earnings from Continuing Operations | -181.05% | -94.30% | -93.53% | -92.73% | -92.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -181.05% | -94.30% | -93.53% | -92.73% | -92.85% |
| EBIT | 73.65% | 90.34% | 90.86% | 80.74% | 71.62% |
| EBITDA | -- | 99.73% | 97.55% | 88.13% | 74.82% |
| EPS Basic | -181.09% | -94.33% | -93.50% | -92.72% | -92.79% |
| Normalized Basic EPS | 7.44% | 85.16% | 89.51% | 93.37% | 91.12% |
| EPS Diluted | -256.05% | -95.96% | -94.24% | -93.29% | -94.35% |
| Normalized Diluted EPS | 7.44% | 85.16% | 89.51% | 93.37% | 91.12% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 1.80% | 2.37% | 3.06% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 1.80% | 2.37% | 3.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |